FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W64488052> ?p ?o ?g. }

• W64488052 endingPage "64" @default.
• W64488052 startingPage "61" @default.
• W64488052 abstract "Context Functional abdominal pain (FAP) is one of the most common functional gastrointestinal disorders (FGIDs) in children. Currently, medical practitioners widely use tricyclic antidepressants to treat FAP. Those antidepressants, however, have been associated with an increased risk of suicidal ideation, and the accompanying side effects often limit the benefits. S-adenosylmethionine (SAM-e) is a dietary supplement that has efficacy as an antidepressant and as a treatment for chronic pain. Objective The research team hypothesized that during SAM-e exposure (1) participants' pain reports would significantly improve over time, (2) participants' reported quality of life would significantly improve over time, and (3) toxicity measures (liver-function tests and mania and depression scales) would not change significantly. Design The research team performed an open-label, doseescalation trial of oral SAM-e among children with FAP. Participants came to the research facility for measurements at baseline and after 2 wk, 1 mo, and 2 mo. The research team monitored participants for potential toxicities (liver toxicity, mania, and depression) throughout the trial. Setting The trial was conducted at the University of California, San Diego. Participants The research team recruited children and adolescents with FAP via advertisement at several community general pediatric clinics and at the research team's subspecialty pediatric gastrointestinal clinic at a tertiary care center. The eight resulting participants were children with a median and mean age of 14 y. Intervention To treat persistent abdominal pain, all participants received SAM-e at an initial dose of 200 mg/d, with escalation to a maximum dose of 1400 mg/d over the period of 2 mo. Outcome measures The primary outcomes were the participants' self-reports of pain and quality of life. The research team used the multidimensional measure for recurrent abdominal pain (MM-RAP), Wong-Baker FACES Pain Rating Scale, and the PedsQL for those measurements. The team used repeated measures analyses to analyze the data. Results Six participants completed the study. The research team demonstrated an improvement in self-pain reports over the 2-mo follow-up period (P = .004). The median dose of SAM-e that participants took at the 2-mo follow-up period was 1400 mg (interquartile range: 950-1400 mg) daily. Liver function tests and assessments for mania and depression did not change over the study period. Conclusions Oral SAM-e demonstrates promise in reducing abdominal pain among children with FAP, with minimal toxicity. The research team needs to conduct larger, placebo-controlled trials to support its initial findings." @default.
• W64488052 created "2016-06-24" @default.
• W64488052 creator A5021487548 @default.
• W64488052 creator A5090447535 @default.
• W64488052 date "2013-09-01" @default.
• W64488052 modified "2023-09-27" @default.
• W64488052 title "A pilot study of S-adenosylmethionine in treatment of functional abdominal pain in children." @default.
• W64488052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23981407" @default.
• W64488052 hasPublicationYear "2013" @default.
• W64488052 type Work @default.
• W64488052 sameAs 64488052 @default.
• W64488052 citedByCount "4" @default.
• W64488052 countsByYear W644880522014 @default.
• W64488052 countsByYear W644880522016 @default.
• W64488052 crossrefType "journal-article" @default.
• W64488052 hasAuthorship W64488052A5021487548 @default.
• W64488052 hasAuthorship W64488052A5090447535 @default.
• W64488052 hasConcept C126322002 @default.
• W64488052 hasConcept C139719470 @default.
• W64488052 hasConcept C151730666 @default.
• W64488052 hasConcept C159110408 @default.
• W64488052 hasConcept C162324750 @default.
• W64488052 hasConcept C1862650 @default.
• W64488052 hasConcept C190385971 @default.
• W64488052 hasConcept C194828623 @default.
• W64488052 hasConcept C2776641880 @default.
• W64488052 hasConcept C2776867660 @default.
• W64488052 hasConcept C2779343474 @default.
• W64488052 hasConcept C2779951463 @default.
• W64488052 hasConcept C2780955771 @default.
• W64488052 hasConcept C3017944768 @default.
• W64488052 hasConcept C535046627 @default.
• W64488052 hasConcept C71924100 @default.
• W64488052 hasConcept C86803240 @default.
• W64488052 hasConceptScore W64488052C126322002 @default.
• W64488052 hasConceptScore W64488052C139719470 @default.
• W64488052 hasConceptScore W64488052C151730666 @default.
• W64488052 hasConceptScore W64488052C159110408 @default.
• W64488052 hasConceptScore W64488052C162324750 @default.
• W64488052 hasConceptScore W64488052C1862650 @default.
• W64488052 hasConceptScore W64488052C190385971 @default.
• W64488052 hasConceptScore W64488052C194828623 @default.
• W64488052 hasConceptScore W64488052C2776641880 @default.
• W64488052 hasConceptScore W64488052C2776867660 @default.
• W64488052 hasConceptScore W64488052C2779343474 @default.
• W64488052 hasConceptScore W64488052C2779951463 @default.
• W64488052 hasConceptScore W64488052C2780955771 @default.
• W64488052 hasConceptScore W64488052C3017944768 @default.
• W64488052 hasConceptScore W64488052C535046627 @default.
• W64488052 hasConceptScore W64488052C71924100 @default.
• W64488052 hasConceptScore W64488052C86803240 @default.
• W64488052 hasIssue "5" @default.
• W64488052 hasLocation W644880521 @default.
• W64488052 hasOpenAccess W64488052 @default.
• W64488052 hasPrimaryLocation W644880521 @default.
• W64488052 hasRelatedWork W1560590504 @default.
• W64488052 hasRelatedWork W17989609 @default.
• W64488052 hasRelatedWork W2012942868 @default.
• W64488052 hasRelatedWork W2025509907 @default.
• W64488052 hasRelatedWork W2064357522 @default.
• W64488052 hasRelatedWork W2075922892 @default.
• W64488052 hasRelatedWork W2107805720 @default.
• W64488052 hasRelatedWork W2121024586 @default.
• W64488052 hasRelatedWork W2138945886 @default.
• W64488052 hasRelatedWork W2147539341 @default.
• W64488052 hasRelatedWork W2296492800 @default.
• W64488052 hasRelatedWork W2800373167 @default.
• W64488052 hasRelatedWork W2890369934 @default.
• W64488052 hasRelatedWork W2896495484 @default.
• W64488052 hasRelatedWork W2965647900 @default.
• W64488052 hasRelatedWork W2995333625 @default.
• W64488052 hasRelatedWork W3045281292 @default.
• W64488052 hasRelatedWork W3094887471 @default.
• W64488052 hasRelatedWork W3199226518 @default.
• W64488052 hasRelatedWork W3205955257 @default.
• W64488052 hasVolume "19" @default.
• W64488052 isParatext "false" @default.
• W64488052 isRetracted "false" @default.
• W64488052 magId "64488052" @default.
• W64488052 workType "article" @default.